These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 9340369)

  • 1. [Plasminogen and apolipoproteins A].
    Ichinose A
    Nihon Naika Gakkai Zasshi; 1997 Jun; 86(6):993-8. PubMed ID: 9340369
    [No Abstract]   [Full Text] [Related]  

  • 2. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen.
    McLean JW; Tomlinson JE; Kuang WJ; Eaton DL; Chen EY; Fless GM; Scanu AM; Lawn RM
    Nature; 1987 Nov 12-18; 330(6144):132-7. PubMed ID: 3670400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA polymorphisms as potential genetic risk markers for cardiovascular diseases.
    Cocozza S; Monticelli A; Garofalo S; Riccardi G; Cortese R; Quirico N; Ricci A; Cicerone R; Rossi F; Varrone S
    Boll Soc Ital Biol Sper; 1987 Sep; 63(9):771-7. PubMed ID: 2896009
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of Lp(a).
    Brown WV; Ballantyne CM; Jones PH; Marcovina S
    J Clin Lipidol; 2010; 4(4):240-7. PubMed ID: 21122656
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular evolution and domain structure of plasminogen-related growth factors (HGF/SF and HGF1/MSP).
    Donate LE; Gherardi E; Srinivasan N; Sowdhamini R; Aparicio S; Blundell TL
    Protein Sci; 1994 Dec; 3(12):2378-94. PubMed ID: 7756992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutants of apolipoproteins A and C.
    Sirtori CR; Lovati MR
    Verh Dtsch Ges Inn Med; 1986; 92():403-12. PubMed ID: 3811541
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetic determinants of dyslipidemias.
    Breslow JL
    Monogr Atheroscler; 1985; 13():25-31. PubMed ID: 3937050
    [No Abstract]   [Full Text] [Related]  

  • 8. [Disorders of apolipoproteins and lipoprotein receptors].
    Itakura H; Matsumoto A
    Nihon Rinsho; 1990 Nov; 48(11):2666-74. PubMed ID: 2125327
    [No Abstract]   [Full Text] [Related]  

  • 9. Several liver specific DNAse hypersensitive sites are present in the intergenic region separating human plasminogen and apoprotein(A) genes.
    Magnaghi P; Mihalich A; Taramelli R
    Biochem Biophys Res Commun; 1994 Nov; 205(1):930-5. PubMed ID: 7999134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 2-Mb YAC contig linking the plasminogen-apoprotein(a) gene family to the insulin-like growth factor 2 receptor (IGF2R) gene on the telomeric region of chromosome 6 (6q26-q27).
    Acquati F; Malgaretti N; Hauptschein R; Rao P; Gaidano G; Taramelli R
    Genomics; 1994 Aug; 22(3):664-6. PubMed ID: 8001987
    [No Abstract]   [Full Text] [Related]  

  • 11. [Molecular patho-biochemistry and genetic diagnosis for plasminogen-apolipoprotein (a) gene family related to atherosclerosis and thrombosis].
    Ichinose A
    Rinsho Byori; 1998 Dec; 46(12):1210-8. PubMed ID: 9916506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cringle conundrums, clotting, cholesterol, and coronaries.
    Luft FC
    J Mol Med (Berl); 1996 Nov; 74(11):637-8. PubMed ID: 8956149
    [No Abstract]   [Full Text] [Related]  

  • 13. Cautious enthusiasm about GWAS findings.
    Gagnon F
    Blood; 2014 Nov; 124(20):3041-2. PubMed ID: 25395143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection and treatment of lipid disorders].
    Barraquer Bordas L
    Rev Clin Esp; 1988 Nov; 183(8):427-32. PubMed ID: 3222513
    [No Abstract]   [Full Text] [Related]  

  • 15. [Apolipoprotein A-I and high-density lipoprotein cholesterol in familial hyperlipoproteinemias].
    Raslová K; Oravec S; Kolesár P; Lukácová M
    Vnitr Lek; 1986 Jun; 32(6):549-55. PubMed ID: 3090780
    [No Abstract]   [Full Text] [Related]  

  • 16. [Detection and treatment of lipid disorders].
    Assmann G; Davignon J; Fernández-Cruz A; Gotto AM; Jacotot B; Lewis B; Paoletti R
    Rev Clin Esp; 1988 Nov; 183(8):433-41. PubMed ID: 3222514
    [No Abstract]   [Full Text] [Related]  

  • 17. Antiangiogenic kringles derived from human plasminogen and apolipoprotein(a) inhibit fibrinolysis through a mechanism that requires a functional lysine-binding site.
    Ahn JH; Lee HJ; Lee EK; Yu HK; Lee TH; Yoon Y; Kim SJ; Kim JS
    Biol Chem; 2011 Apr; 392(4):347-56. PubMed ID: 21194375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant gene expression and 1H NMR characteristics of the kringle (2 + 3) supermodule: spectroscopic/functional individuality of plasminogen kringle domains.
    Söhndel S; Hu CK; Marti D; Affolter M; Schaller J; Llinás M; Rickli EE
    Biochemistry; 1996 Feb; 35(7):2357-64. PubMed ID: 8652577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dyslipoproteinemias and coronary disease. Genetic markers].
    Sarriá Chueca A; Moreno Aznar L; Bueno Lozano G; Bueno Sánchez M
    An Esp Pediatr; 1989 Jun; 30(6):425-8. PubMed ID: 2572193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genetic studies in familial hyperlipoproteinemia, and therapeutic implications].
    de Gennes JL
    Ann Biol Clin (Paris); 1988; 46(1):1-3. PubMed ID: 3389574
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.